Regenerative Biologics Supplier for Louisville, KY Medspas

Vendor review for medspas and aesthetic practices

Medspas operate under physician supervision, so a new biologics vendor typically goes through the supervising physician or medical director before it reaches the treatment room. That review tends to focus on documentation: donor screening and serology testing at the time of donation, the processing timeline, and sterility testing results tied to a specific lot.

Because medspa purchasing is often centralized at the practice or group level, Precision Biologics makes certificate-of-analysis and donor eligibility documentation available per lot so a single verified account can support several locations under one supervising physician.

NPI verification and account structure

Accounts require a verified NPI number tied to the supervising physician. This keeps purchasing authority with the licensed professional responsible for the practice rather than with general staff accounts, which matters for a medspa where multiple non-physician staff may handle day-to-day ordering.

Receiving shipments in Louisville

Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated containers and are stored at -80 degrees C, so a practice should assign someone to check container temperature and log the lot number at delivery. Several exosome formats and the lyophilized Wharton's jelly product are shelf-stable, which simplifies storage for a practice that does not want to maintain ultra-low-temperature freezer space.

Compliance posture before ordering

Exosome products carry no FDA approval; FDA has publicly stated that no exosome product is FDA-approved, and these products are generally regulated as biologic drugs. For Wharton's jelly products, whether a specific intended use satisfies the minimal-manipulation and homologous-use conditions of 21 CFR 1271.10 is a determination the practice and its own counsel must make. A medspa should also confirm its supervising physician's standing with the Kentucky medical board as part of its own review.

Precision Biologics supports new accounts with a physician-level documentation call and NPI-based verification, and makes product documentation available to the supervising physician rather than issuing clinical guidance.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.